​Martin Henman is Adjunct Associate Professor in the Practice of Pharmacy. His interests are pharmacoepidemiology and health services research. He is part of the Intellectual Disability Supplement to TILDA (IDS-TILDA) cohort study. He is a Consultant to the European Directorate for the Quality and Safety of Medicines and Pharmaceutical Care and a Fellow of FIP and of ESCP.